Candida (CD-1)
Candida (CD-1)
Also known as: CD-1, Candida CD-1
Overview
Candida (CD-1) is a groundbreaking high-CBD cannabis strain developed by Medical Marijuana Genetics in Europe in 2015. Named after the founder's late mother, the name means 'bright light' in Latin. This strain represents one of the first consistently CBD-dominant varieties to achieve a 20:1 CBD to THC ratio, making it one of the most significant medical cannabis breakthroughs in Europe. The strain was developed specifically for medicinal use following the founders' experience treating pancreatic cancer symptoms with cannabis oil. Candida produces two distinct phenotypes - a sativa-leaning phenotype that tends to have higher CBD concentrations but lower yields, and an indica-leaning phenotype that produces denser, heavier yields with slightly lower but still substantial CBD content. The sativa phenotype is particularly well-suited for extractions and concentrates, while the indica phenotype is suitable for all consumption methods. Laboratory testing consistently shows CBD levels between 10.9% and 20.6% with THC never exceeding 1%, resulting in non-psychoactive effects that provide medicinal benefits without the traditional cannabis 'high'. The strain has won multiple awards, including 2nd place at the Spannabis Cannabis Champions Cup 2017 in the CBD Flowers category.
Effects
Reported Medical Uses
- Users report relief from chronic pain
- May help with anxiety and depression
- Often used for epilepsy and seizures
- Users report benefits for inflammation
- May help with insomnia in larger doses
- Often used for ADHD and ADD
- Users report relief from nausea and vomiting
- May help with autism-related symptoms
- Often used for anorexia
- Users report benefits for PTSD
This is not medical advice. Consult a healthcare professional.
Possible Negative Effects
- Dry Mouth
- Dry mouth
- Minimal side effects due to low THC
Growing Information
Candida is suitable for both indoor and outdoor cultivation with moderate difficulty. Flowering time is 8-9 weeks indoors, with outdoor harvest ready by early October. Indoor yields range from 400-450g/m² (up to 550g/m² with SOG technique for indica phenotype), while outdoor yields exceed 500g per plant. Plants typically reach 80-140cm in height. The strain thrives in any climate and is adaptable to various growing media. It requires staking due to very flexible branches and becomes extremely sticky during harvest. The sativa phenotype can be more challenging to manage with larger internodal spacing, while the indica phenotype is generally easier to grow with denser, more compact structure.